Home
Science
Science News
Apple Awards $10 Million to Nasal Swab Maker COPAN Diagnostics to Help Boost Factory Output

Apple Awards $10 Million to Nasal Swab Maker COPAN Diagnostics to Help Boost Factory Output

Shortages of collection kits and testing supplies have slowed efforts to track the spread of the novel coronavirus in the United States.

By Reuters | Updated: 7 May 2020 19:28 IST

Apple Awards $10 Million to Nasal Swab Maker COPAN Diagnostics to Help Boost Factory Output

“We feel a deep sense of responsibility to do everything we can to help," Apple COO Jeff Williams said.

Click Here to Add Gadgets360 As A Trusted Source

Highlights

Shortage of collection kits has slowed efforts to track coronavirus in US
The corporate parent of COPAN Diagnostics is based in Italy
Apple did not specify the nature of the funding

Apple said on Thursday that it was awarding $10 million (roughly Rs. 75 crores) to a maker of nasal swabs and other materials for collecting samples for COVID-19 tests in a move aimed at boosting the swab maker's production to 1 million collection kits per week by early July.

The two companies said the award would help Murrieta, California-based COPAN Diagnostics expand into a larger facility and create 50 new jobs in Southern California. In addition to providing the funding, Apple said it would help COPAN Diagnostics design and source new equipment from York, Pennsylvania-based K2 Kinetics, and Waukesha, Wisconsin-based MWES, both makers of industrial robotics systems.

Shortages of collection kits and testing supplies have slowed efforts to track the spread of the novel coronavirus in the United States. The corporate parent of COPAN Diagnostics, COPAN Group, is based in the Lombardy region of Italy, one of the worst-hit regions in the world during the pandemic, and stepped up production as demand surged.

In California, COPAN Diagnostics makes specialized nasal swabs to collect samples for COVID-19 tests, along with vials and sterile media used to transport those swabs to labs for testing. The companies said Apple's help would expand production of sample kits destined for US hospitals from a current several thousand per week to more than one million kits per week by early July.

In a statement, Norman Sharples, chief executive of COPAN Diagnostics, said Apple's "teams are already making a huge difference with our efforts to scale up the production of our sample collection and transport kits.”

Apple did not specify the nature of the funding but made the award from a $5 billion (roughly Rs. 37,900 crores) advanced manufacturing fund. The iPhone maker previously used the fund to support expansions and research at its suppliers, such as Corning, which makes glass for iPhones, and II-VI Inc-owned Finisar, which makes chips for Apple's face recognition sensors.

“We feel a deep sense of responsibility to do everything we can to help medical workers, patients, and communities support the global response to COVID-19,” Jeff Williams, Apple's chief operating officer, said in a statement.

© Thomson Reuters 2020

Is Mi 10 an expensive OnePlus 8 or a budget budget S20 Ultra? We discussed this on Orbital, our weekly technology podcast, which you can subscribe to via Apple Podcasts or RSS, download the episode, or just hit the play button below.

Comments

Get your daily dose of tech news, reviews, and insights, in under 80 characters on Gadgets 360 Turbo. Connect with fellow tech lovers on our Forum. Follow us on X, Facebook, WhatsApp, Threads and Google News for instant updates. Catch all the action on our YouTube channel.